Related Experiment Video
Updated: Apr 5, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Associations between cardiovascular risk factors and psoriasis in Iran
Mahmoud Farshchian1, Akram Ansar1, Mohammadreza Sobhan1
1Psoriasis Research Center, Department of Dermatology, Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.
Insights
Psoriasis patients show higher triglyceride and LDL cholesterol levels, alongside increased smoking and hypertension rates, indicating elevated cardiovascular disease risk. Regular monitoring of lipid profiles and blood pressure is recommended for early intervention.
Area of Science:
- Dermatology
- Cardiology
- Clinical Research
Background:
- Psoriasis is a chronic inflammatory skin condition linked to increased cardiovascular disease (CVD) risk.
- Hyperlipidemia is more prevalent in psoriasis patients, contributing to their heightened CVD risk.
Purpose of the Study:
- To investigate the association between cardiovascular risk factors and psoriasis.
- To compare lipid profiles and other risk factors between psoriasis patients and a control group.
Main Methods:
- A cross-sectional study involving 55 psoriasis patients and 55 matched controls.
- Serum lipid levels (triglyceride, cholesterol, HDL, LDL) were measured after fasting.
- Data on demographics, lifestyle (smoking, alcohol), and hypertension were collected.
Main Results:
- Psoriasis patients exhibited significantly higher triglyceride and LDL levels, and increased smoking prevalence.
- No significant difference in HDL cholesterol or overall cholesterol levels was observed.
- Hypertension was more common in patients with psoriasis, despite similar BMI compared to controls.
Conclusions:
- Psoriasis is associated with dyslipidemia, particularly elevated triglycerides and LDL, and a higher prevalence of hypertension.
- These factors contribute to an increased risk of cardiovascular diseases in psoriasis patients.
- Routine monitoring of lipid profiles and blood pressure is crucial for all psoriasis patients.
Background:
Psoriasis is a common chronic inflammatory skin disease. There is overwhelming evidence on the higher risk of cardiovascular diseases in patients with psoriasis as a result of hyperlipidemia, which is more common in these patients.
Objectives:
The aim of this study was to elucidate the association between the cardiovascular risk factors and psoriasis.
Methods:
In a cross-sectional study, 55 patients with psoriasis and 55 matched (sex and age) controls were entered the study at the Department of Dermatology between March 2011 and March 2013. Blood samples were obtained following 14 hours fasting status and serum levels of triglyceride, cholesterol, high-density lipoprotein, and low-density lipoprotein were determined using standard laboratory methods, and other variables such as sex, age, smoking, alcohol consumption, and the type of disease were recorded.
Results:
Our findings showed that levels of triglyceride, low-density lipoprotein, and smoking were significantly higher in psoriatic patients when compared with controls, whereas the level of high-density lipoprotein and cholesterol was not significantly different between two groups. Body mass index of psoriatic patients was not significantly higher than controls. Patients with psoriasis also had an increased prevalence of hypertension.
Conclusion:
Our findings further verify lipid abnormalities in psoriatic patients. Psoriasis is associated with higher rate of hypertension, which may be resulted in increasing the risk of cardiovascular diseases in these patients. Thus, serum lipid profile and blood pressure in all patients with psoriasis, regardless of disease severity, deserve consideration to be checked.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures

